U. Holwerda
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 2
-
- Genetic factors in colorectal cancer 3
- Chemotherapy-induced organ toxicity mitigation 2
- Co-authors
- Herbert M. Pinedo (5 shared papers)Paul Noordhuis (6 shared papers)Godefridus J. Peters (6 shared papers)Kees Smid (2 shared papers)C.L. van der Wilt (3 shared papers)Sybren L. Meijer (1 shared paper)C.J. van Groeningen (1 shared paper)M. Treskes (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Gene (1 paper)Clinical Cancer Research (1 paper)Clinical Chemistry (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)
- Partner nations
- NetherlandsPortugalBelgium
In The Last Decade
U. Holwerda
13 papers receiving 558 citations
Peers
Comparison fields: 5 of 82
- Clinical Biochemistry 87
- Oncology 216
- Pathology and Forensic Medicine 67
- Cancer Research 56
- Molecular Biology 254
Countries citing papers authored by U. Holwerda
This map shows the geographic impact of U. Holwerda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Holwerda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Holwerda more than expected).
Fields of papers citing papers by U. Holwerda
This network shows the impact of papers produced by U. Holwerda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Holwerda. The network helps show where U. Holwerda may publish in the future.
Co-authors
The 25 scholars most cited alongside U. Holwerda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 210 | |
| 2 | 1998 | 87 | |
| 3 | Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse. | 1992 | 61 |
| 4 | 2003 | 39 | |
| 5 | 1991 | 39 | |
| 6 | 2000 | 38 | |
| 7 | 1992 | 25 | |
| 8 | 2015 | 23 | |
| 9 | 1995 | 23 | |
| 10 | 2004 | 18 | |
| 11 | 2004 | 6 | |
| 12 | 2017 | 2 | |
| 13 | 2005 | 1 |
About U. Holwerda
U. Holwerda is a scholar working on Oncology, Pathology and Forensic Medicine, Clinical Biochemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 572 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Metabolism and Genetic Disorders (4 papers), Genetic factors in colorectal cancer (3 papers), Gastric Cancer Management and Outcomes (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Muscle metabolism and nutrition (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Clinical Biochemistry (87 citations), Oncology (216 citations), Pathology and Forensic Medicine (67 citations), Cancer Research (56 citations) and Molecular Biology (254 citations). U. Holwerda has collaborated with scholars based in Netherlands, Portugal and Belgium. Frequent co-authors include Herbert M. Pinedo, Paul Noordhuis, Godefridus J. Peters, Kees Smid, C.L. van der Wilt, Sybren L. Meijer, C.J. van Groeningen, M. Treskes, Isabel Tavares de Almeida and W. J. F. van der Vijgh. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Gene, Clinical Cancer Research, Clinical Chemistry and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.